Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 20, 2020 - Issue 5
Submit an article Journal homepage
3,158
Views
2
CrossRef citations to date
0
Altmetric
Editorial

How close is ketamine to routine use in refractory status epilepticus?

Yin YanDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, ChinaView further author information
,
Xiaoyan PengDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, ChinaView further author information
,
Wei JingDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China;Department of Neurology, Shanxi Bethune Hospital of Shanxi Aademy of Medical Sciences, Taiyuan, Shanxi, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Xuefeng WangDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, ChinaCorrespondence[email protected] [email protected]
View further author information
Pages 421-423 | Received 12 Mar 2019, Accepted 15 Apr 2020, Published online: 19 Apr 2020

References

  • Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus–report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515–1523.
  • Dorandeu F. Ketamine for the treatment of (super) refractory status epilepticus? Not quite yet. Expert Rev Neurother. 2017;17(5):419–421.
  • Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739–744.
  • International league against epilepsy, https://www.ilae.org/
  • Perl TM, Bedard L, Kosatsky T, et al. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. N Engl J Med. 1990;322(25):1775–1780.
  • John PB, Daniel HL. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615–624.
  • Samanta D. Ketamine infusion for super refractory status epilepticus in alternating hemiplegia of childhood. Neuropediatrics. 2020 Feb 3(Epub ahead of print).
  • Gugger JJ, Husari K, Probasco JC, et al. New-onset refractory status epilepticus: A retrospective cohort study. Seizure. 2020;74:41–48.
  • Gautam CS, Mahajan SS, Sharma J, et al. Repurposing potential of ketamine: opportunities and challenges. Indian J Psychol Med. 2020;42(1):22–29.
  • Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14-20.
  • Wang X, Li S. Refractory status epilepticus: diagnosis and treatment. Singapore: Springer; 2017.
  • Hofler J, Rohracher A, Kalss G, et al. (S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs. 2016;30(9):869–876.
  • Ilvento L, Rosati A, Marini C, et al. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343–346.
  • Pizzi MA, Kamireddi P, Tatum WO, et al. Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus. J Intensive Care. 2017;5(54).
  • Santoro JD, Filippakis A, Chitnis T. Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis. Epilepsy Behav Rep. 2019;12:100326.
  • Li D, Yuan H, Ortiz-Gonzalez XR, et al. GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers. Am J Hum Genet. 2016;99(4):802–816.
  • Fujikawa DG. Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus. Epilepsia. 2019;60(3):373–380.
  • Zhou Y, Mannan A, Han Y, et al. Efficacy and safety of prophylactic use of ketamine for prevention of postanesthetic shivering: a systematic review and meta analysis. BMC Anesthesiol. 2019;19(1):245.
  • Talahma M, Sabharwal V, Bukovskaya Y, et al. Ketamine infusion used to successfully control refractory status epilepticus in a pregnant patient. Case Rep Neurol Med. 2018;2018:3041279.
  • Sabharwal V, Poongkunran M, Talahma M, et al. Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine. Epilepsy Behav. 2020;105:106960.
  • Meaden CW, Barnes S. Ketamine implicated in new onset seizure. Clin Pract Cases Emerg Med. 2019;3(4):401–404.
  • Holtkamp M. Pharmacotherapy for refractory and super-refractory status epilepticus in adults. Drugs. 2018;78(3):307–326.
  • Rosati A, Ilvento L, L’Erario M, et al. Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). BMJ Open. 2016;6(6):e011565.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.